"Thanks to effective vaccine, the United States has been polio-free since 1979. But poliovirus is still a threat in some countries. Be part of the success story and get your child vaccinated on schedule.
Polio, or poliomyelitis, is an in"...
Menomune Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Menomune (A/C/Y/W-135 Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined) is used to prevent infection caused by meningococcal bacteria. The vaccine contains four of the most common types of meningococcal bacteria. It is a vaccine. Common side effects include pain, redness, swelling, and tenderness at the injection site that usually lasts 1-2 days. Headache and fever may also occur.
For both adults and children, Menomune vaccine is administered subcutaneously as a single 0.5 mL dose. Menomune may interact with blood thinners, azathioprine, basiliximab, cyclosporine, etanercept, leflunomide, muromonab-CD3, mycophenolate mofetil, sirolimus, tacrolimus, chemotherapy or radiation treatment, or steroids. Tell your doctor all medications and supplements you use, and other recent vaccines you have had. Menomune should be used only when prescribed during pregnancy. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Menomune (A/C/Y/W-135 Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Menomune in Detail - Patient Information: Side Effects
Keep track of any and all side effects you have after receiving this vaccine. If you ever need to receive another meningococcal vaccine in the future, you will need to tell the doctor if the first shot caused any side effects.
Developing meningitis (infection of the spinal cord and lining of the brain) is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects but the risk of serious side effects is extremely low.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:
- severe weakness or unusual feeling in your arms and legs (may occur 2 to 4 weeks after you receive the vaccine);
- high fever; or
- unusual bleeding.
Less serious side effects may include:
- low fever, chills;
- redness, pain, swelling, or a lump where the vaccine was injected;
- headache; or
- tired feeling.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.
Read the entire detailed patient monograph for Menomune (Meningococcal Polysaccharide Vaccine) »
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Menomune Overview - Patient Information: Side Effects
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
Contact your doctor for medical advice about side effects. The following numbers do not provide medical advice, but in the US, you may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967. In Canada, you may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Menomune (Meningococcal Polysaccharide Vaccine)»
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Menomune FDA Prescribing Information: Side Effects
Adverse reactions to meningococcal vaccine are mild and consist principally of pain and redness at the injection site for 1 to 2 days.Pain at the site of injection is the most commonly reported adverse reaction, and a transient fever might develop in less than or equal to 2% ofyoung children.5
Adverse events reported by 150 adults following vaccination with Menomune (meningococcal polysaccharide vaccine) - A/C/Y/W-135 vaccine are shown in Table 1.14 The subjects were observed for three weeks following vaccination. Local reactions resolved within 48 hours and no significant systemic reactions were reported.14
ADVERSE EVENTS (%) FOLLOWING VACCINATION OF 150 ADULTS WITH MENOMUNE (meningococcal polysaccharide vaccine) - A/C/Y/W-135 VACCINE
|Diameter||<2 in.||≥ 2 in.|
|Oral Temperature (°F)||2.6 (100-101)||0.6 (>101)|
In a clinical study involving 73 children 2 to 12 years of age, who received Menomune (meningococcal polysaccharide vaccine) - A/C/Y/W-135 vaccine, local reactions consisting of erythema or tenderness were seen in approximately 40% of the children.15 In another clinical study involving 53 children 4 to 6 years of age, who received Menomune (meningococcal polysaccharide vaccine) - A/C/Y/W-135 vaccine, erythema was seen in 89% of the children, swelling in 92% and tenderness in 64%. None of these reactions were considered serious or necessitated medical intervention.26
On rare occasions, IgA nephropathy has occurred following vaccinations with Menomune (meningococcal polysaccharide vaccine) - A/C/Y/W-135 vaccine. However, a cause and effect relationship has not been established.16
Menomune (meningococcal polysaccharide vaccine) - A/C/Y/W-135 vaccine should NOT be given at the same time as whole-cell pertussis or whole-cell typhoid vaccines due to combined endotoxin content.20,21
As with the administration of any vaccine, vaccine components can cause hypersensitivity reactions in some recipients.
Reporting of Adverse Events
The National Vaccine Injury Compensation Program, established by the National Childhood Vaccine Injury Act of 1986, requires physicians and other health-care providers who administer vaccines to maintain permanent vaccination records and to report occurrences of certain adverse events to the US Department of Health and Human Services. Reportable events include those listed in the Act for each vaccine and events specified in the package insert as contraindications to further doses of that vaccine.22,23,24
Reporting by patients, parents or guardians of all adverse events occurring after vaccine administration should be encouraged. Adverse events following immunization with vaccine should be reported by the health-care provider to the US Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting Systems (VAERS). Reporting forms and information about reporting requirements or completion of the form can be obtained from VAERS through a toll-free number 1-800-822-7967.24
Health-care providers also should report these events to the Pharmacovigilance Department, Sanofi Pasteur Inc., Discovery Drive, Swiftwater, PA 18370 or call 1-800-822-2463.
Read the entire FDA prescribing information for Menomune (Meningococcal Polysaccharide Vaccine) »
Additional Menomune Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.